David Molowa has joined MPM BioEquities as a general partner based in New York. He previously was with Venrock and served as a strategic advisor to Amgen. MPM BioEquities is a private fund that invests in public biotech companies and, to a lesser extent, private biotech companies. www.mpmcapital.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.